Skip to search.
 FTSE 100 Down 1.18%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.10 Down 0.09(2.15%) 26 May 21:00
|After Hours: : 4.10 0.00 (0.00%) 26 May 21:29
Add to Portfolio
Prev Close:4.19
Open:4.18
Bid:4.10 x 900
Ask:4.20 x 200
1y Target Est:7.08
Beta:-4.69
Earnings Date:30 Jul - 3 Aug (Est.)
Day's Range:4.10 - 4.24
52wk Range:3.26 - 6.59
Volume:1,822,349
Avg Vol (3m):3,826,850
Market Cap:992.35m
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 2.15%992.35m
GSKDown 3.14%105.87b
OREXDown 1.30%611.83m
RHHBYDown 1.62%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.52
Quarterly EPS Est (Jun-15) :-0.14
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback